Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), a clinical stage innovative drug development company focused on developing innovative therapies for immune and ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated ...
Novel small molecule inhibitors show promising efficacy in endometrial cancer, with ongoing trials expanding treatment ...
Plant City, Florida - January 09, 2026 - PRESSADVANTAGE - WhiteSands Alcohol & Drug Rehab Plant City has published ...
PsyPost on MSN
Neuroscientists link a common inflammatory molecule to the dopaminergic mechanisms of addiction
A new study published in the journal Science Signaling has found that an immune system protein plays a central role in the ...
The Cool Down on MSN
Researchers make incredible breakthrough in fight against looming threat to food supply: 'A promising path'
This could be a big boost for crop production. Researchers make incredible breakthrough in fight against looming threat to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback